On behalf of our team at OmniPathology Laboratory, we are pleased to announce the promotion of Ronald A. Blum, Ph.D. to Senior Vice President, Strategic Growth and Innovation. Since joining us in October 2024, Dr. Blum has supported the buildout of our digital pathology program and has played a significant role in expanding our oropharyngeal HPV testing, where we see real opportunity to improve early detection of oropharyngeal cancer. He has also been instrumental in broadening our clinical trials reach. OmniPathology is one of the leading GI pathology practices in California, and work like this is how we extend that foundation into new capabilities and new markets. Please join us in congratulating Dr. Blum on this well-earned step.
Pictured L to R: Mohammad Kamal, MD (CEO, OmniPathology), Ron Blum, PhD (Sr. VP, Strategic Growth & Innovation, OmniPathology)
